Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Its primary function is to stimulate the pituitary gland to produce and release growth hormone. Consequently, this action can indirectly influence metabolic processes within the body. For instance, increased growth hormone levels are associated with enhanced lipolysis, the breakdown of fats, which may contribute to alterations in body composition.
The potential advantage of utilizing a GHRH analog lies in its ability to stimulate the body’s natural production of growth hormone, rather than introducing synthetic growth hormone directly. This approach theoretically maintains a more physiological release pattern, potentially minimizing some of the adverse effects associated with exogenous growth hormone administration. Historical context reveals its initial use in diagnosing growth hormone deficiencies and subsequently its exploration in anti-aging and wellness applications.
